D
Daniel M. Labow
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 118
Citations - 5266
Daniel M. Labow is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Medicine. The author has an hindex of 29, co-authored 95 publications receiving 4449 citations. Previous affiliations of Daniel M. Labow include Memorial Sloan Kettering Cancer Center & Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
The international position on laparoscopic liver surgery: The Louisville Statement, 2008.
Joseph F. Buell,Daniel Cherqui,David A. Geller,Nicholas O'Rourke,David A. Iannitti,Ibrahim Dagher,Alan J. Koffron,M.J. Thomas,Brice Gayet,Ho-Seong Han,Go Wakabayashi,Giulio Belli,Hironori Kaneko,Chen Guo Ker,Olivier Scatton,Alexis Laurent,Eddie K. Abdalla,Prosanto Chaudhury,Erik Dutson,Clark Gamblin,Michael I. D’Angelica,David M. Nagorney,Giuliano Testa,Daniel M. Labow,Derrik Manas,Ronnie T.P. Poon,Heidi Nelson,Robert C.G. Martin,Bryan M. Clary,Wright C. Pinson,John B. Martinie,Jean Nicolas Vauthey,Robert M. Goldstein,Sasan Roayaie,David Barlet,Joseph Espat,Michael Abecassis,Myrddin Rees,Yuman Fong,Kelly M. McMasters,Christoph E. Broelsch,Ronald W. Busuttil,Jacques Belghiti,Steven M. Strasberg,Ravi S. Chari +44 more
TL;DR: Laparoscopic liver surgery is a safe and effective approach to the management of surgical liver disease in the hands of trained surgeons with experience in hepatobiliary and laparoscopic surgery, and national and international societies should become involved in the goal of establishing training standards and credentialing.
Journal ArticleDOI
A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma
Sasan Roayaie,Iris N. Blume,Swan N. Thung,Maria Guido,Maria Isabel Fiel,Spiros P. Hiotis,Daniel M. Labow,Josep M. Llovet,Josep M. Llovet,Myron Schwartz +9 more
TL;DR: A novel classification system that includes invasion of a vessel with a muscular wall and invasion ofA vessel that is more than 1 cm from the tumor can accurately predict risk of recurrence and survival of patients with mVI after resection of HCC.
Journal ArticleDOI
Prospective Randomized Clinical Trial of the Value of Intraperitoneal Drainage After Pancreatic Resection
Kevin C. Conlon,Daniel M. Labow,Dennis Leung,Alex Smith,William R. Jarnagin,Daniel G. Coit,Nipum Merchant,Murray F. Brennan +7 more
TL;DR: The data suggest that the presence of drains failed to reduce either the need for interventional radiologic drainage or surgical exploration for intraabdominal sepsis, and closed suction drainage should not be considered mandatory or standard after pancreatic resection.
Journal ArticleDOI
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
Sasan Roayaie,Khaled Obeidat,Carlo Sposito,Luigi Mariani,Sherrie Bhoori,Alessandro Pellegrinelli,Daniel M. Labow,Josep M. Llovet,Myron Schwartz,Vincenzo Mazzaferro +9 more
TL;DR: Resection of HCC ≤2 cm is safe and achieves excellent results in Western centers and should continue to be considered a primary treatment modality in patients with small HCC and well‐preserved liver function.
Journal ArticleDOI
Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States
Kiran K. Turaga,Edward A. Levine,Robert M. Barone,Robert P. Sticca,Nicholas J. Petrelli,Laura A. Lambert,Garrett M. Nash,Michael A. Morse,R. Adbel-Misih,H.R. Alexander,F. Attiyeh,David L. Bartlett,A. Bastidas,T. Blazer,Quyen D. Chu,K. Y. Chung,L. Dominguez-Parra,N. J. Espat,Jason M. Foster,Keith Fournier,Reynaldo Garcia,Michael D. Goodman,Nader Hanna,Lawrence E. Harrison,Richard A. Hoefer,Matthew P. Holtzman,John M. Kane,Daniel M. Labow,Benjamin D.L. Li,Andrew M. Lowy,Paul F. Mansfield,E. Ong,Colette R. Pameijer,James F. Pingpank,M. Quinones,Richard E. Royal,George I. Salti,Armando Sardi,Perry Shen,Joseph J. Skitzki,J. Spellman,John H. Stewart,Jesus Esquivel +42 more
TL;DR: This recommendation on a standardized delivery of HIPEC in patients with colorectal cancer represents an important first step in enhancing research in this field and studies directed at maximizing the efficacy of each of the key elements will need to follow.